Publication | Open Access
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
206
Citations
43
References
2023
Year
DysbiosisCancer ImmunosurveillanceMucosal ImmunologyClinical ResponsesImmunologyPathologyAutoimmunityNon-antibiotic-disrupted Gut MicrobiomeIntestinal MicrobiotaMicrobiomeImmunotherapyMedicineGut Barrier
| Year | Citations | |
|---|---|---|
Page 1
Page 1